Kwong Lung Enterprise Co., Ltd. (TPEX:8916)
Taiwan · Delayed Price · Currency is TWD 47.10
0.00 (0.00%)
At close: Mar 27, 2026
Kwong Lung Enterprise Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 8,538 | 7,893 | 7,708 | 10,304 | 8,061 | |
Revenue Growth (YoY) | 8.17% | 2.40% | -25.19% | 27.83% | -5.16% |
Cost of Revenue | 7,228 | 6,528 | 6,326 | 8,541 | 7,072 |
Gross Profit | 1,310 | 1,365 | 1,382 | 1,763 | 988.66 |
Selling, General & Admin | 745.73 | 727.08 | 681.46 | 749.08 | 674.32 |
Research & Development | 55.62 | 50.99 | 53.07 | 50.91 | 48.82 |
Operating Expenses | 835.16 | 788.76 | 784.9 | 809.49 | 800.8 |
Operating Income | 474.61 | 576.64 | 597.23 | 953.71 | 187.87 |
Interest Expense | -50.42 | -35.57 | -25.34 | -20.96 | -13.92 |
Interest & Investment Income | 46.8 | 57.73 | 61.24 | 37.61 | 23.12 |
Earnings From Equity Investments | -20.66 | -13.79 | 23.06 | 25.77 | 118.75 |
Currency Exchange Gain (Loss) | - | 47.49 | 28.37 | 207.3 | -28.73 |
Other Non Operating Income (Expenses) | 57.14 | 19.7 | 63.14 | -86.74 | -8.17 |
EBT Excluding Unusual Items | 507.47 | 652.2 | 747.71 | 1,117 | 278.91 |
Gain (Loss) on Sale of Investments | - | 83.4 | - | -8.73 | - |
Gain (Loss) on Sale of Assets | - | -0.07 | -1.29 | 23.13 | 332.27 |
Other Unusual Items | - | 6.25 | - | - | - |
Pretax Income | 507.47 | 741.78 | 746.42 | 1,131 | 611.18 |
Income Tax Expense | 130.34 | 135.38 | 169.27 | 213.6 | 121.43 |
Earnings From Continuing Operations | 377.13 | 606.4 | 577.15 | 917.49 | 489.75 |
Minority Interest in Earnings | 0.21 | 2.89 | 0.55 | 1.6 | 25.54 |
Net Income | 377.34 | 609.29 | 577.7 | 919.08 | 515.29 |
Preferred Dividends & Other Adjustments | - | 0.87 | 2.85 | 45.5 | 45.5 |
Net Income to Common | 377.34 | 608.42 | 574.84 | 873.58 | 469.79 |
Net Income Growth | -38.07% | 5.47% | -37.14% | 78.36% | 49.62% |
Shares Outstanding (Basic) | 151 | 151 | 146 | 134 | 131 |
Shares Outstanding (Diluted) | 153 | 152 | 152 | 151 | 150 |
Shares Change (YoY) | 0.53% | 0.22% | 0.51% | 0.49% | 0.11% |
EPS (Basic) | 2.50 | 4.04 | 3.93 | 6.54 | 3.58 |
EPS (Diluted) | 2.47 | 4.00 | 3.79 | 5.79 | 3.13 |
EPS Growth | -38.25% | 5.54% | -34.54% | 84.98% | 57.29% |
Free Cash Flow | 930.12 | -250.78 | 987.67 | 1,317 | -803.49 |
Free Cash Flow Per Share | 6.09 | -1.65 | 6.51 | 8.73 | -5.35 |
Dividend Per Share | - | 3.592 | 3.600 | 4.000 | 3.000 |
Dividend Growth | - | -0.21% | -10.00% | 33.33% | - |
Gross Margin | 15.34% | 17.30% | 17.93% | 17.11% | 12.26% |
Operating Margin | 5.56% | 7.31% | 7.75% | 9.26% | 2.33% |
Profit Margin | 4.42% | 7.71% | 7.46% | 8.48% | 5.83% |
Free Cash Flow Margin | 10.89% | -3.18% | 12.81% | 12.78% | -9.97% |
EBITDA | 645.39 | 695.81 | 716.01 | 1,081 | 330.22 |
EBITDA Margin | 7.56% | 8.82% | 9.29% | 10.49% | 4.10% |
D&A For EBITDA | 170.78 | 119.17 | 118.78 | 127.61 | 142.36 |
EBIT | 474.61 | 576.64 | 597.23 | 953.71 | 187.87 |
EBIT Margin | 5.56% | 7.31% | 7.75% | 9.26% | 2.33% |
Effective Tax Rate | 25.69% | 18.25% | 22.68% | 18.88% | 19.87% |
Revenue as Reported | 8,538 | - | - | - | - |
Advertising Expenses | - | - | - | - | 360.85 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.